YABAO PHARMACEUTICAL GROUP CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.11 CNY | -1.13% |
|
-4.08% | -11.45% |
| Apr. 16 | Yabao Pharma Gets Nod to Register Asthma Drug Montelukast Sodium Granules | MT |
| Apr. 02 | Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023. | CI |
| Sales 2021 | 2.76B 382M | Sales 2022 | 2.72B 375M | Capitalization | 4.53B 625M |
|---|---|---|---|---|---|
| Net income 2021 | 187M 25.83M | Net income 2022 | 105M 14.51M | EV / Sales 2021 | 2.55 x |
| Net Debt 2021 | 61.69M 8.52M | Net cash position 2022 | 227M 31.34M | EV / Sales 2022 | 1.58 x |
| P/E ratio 2021 |
37.4
x | P/E ratio 2022 |
43.3
x | Employees | 4,367 |
| Yield 2021 |
0.88% | Yield 2022 |
0.85% | Free-Float | 84.73% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +3.34% | ||
| 1 week | -2.98% | ||
| Current month | -0.48% | ||
| 1 month | -1.28% | ||
| 3 months | -5.21% | ||
| 6 months | -25.00% | ||
| Current year | -10.43% |
1 week
5.97
6.33
1 month
5.916.55
Current year
4.947.08
1 year
4.949.00
3 years
4.9411.90
5 years
4.5011.90
10 years
4.5019.50
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Ren
CEO | Chief Executive Officer | 40 | 19-04-22 |
Zhe Feng Zuo
DFI | Director of Finance/CFO | 52 | - |
Wu Xian Ren
CHM | Chairman | 64 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wu Xian Ren
CHM | Chairman | 64 | - |
Zhen Jiang Xu
CHM | Chairman | 51 | 14-05-14 |
Peng Bo Ren
BRD | Director/Board Member | 51 | 07-03-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 6.11 | -1.13% | 13 736 000 |
| 24-04-17 | 6.18 | +3.34% | 18,231,300 |
| 24-04-16 | 5.98 | -2.92% | 16,898,910 |
| 24-04-15 | 6.16 | -0.96% | 16,519,070 |
| 24-04-12 | 6.22 | -1.11% | 11,440,880 |
End-of-day quote Shanghai S.E., April 16, 2024
More quotes
YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the wholesaling and trading of pharmaceuticals. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -10.43% | 645M | |
| +20.40% | 44.1B | |
| +17.11% | 21.97B | |
| +8.10% | 13.27B | |
| +6.76% | 13.22B | |
| +35.95% | 11.36B | |
| -8.53% | 7.07B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.09% | 5.23B |
- Stock Market
- Equities
- 600351 Stock
